In the past year, many telehealth and digital health companies have jumped into the market, offering prescriptions for GLP-1s as part of an existing weight loss or chronic condition management program, or creating a new service line targeting obesity care
Mautner VF, Friedrich RE, von Deimling A, Hagel C, Korf B, Knofel MT, et al
If the solution looks discolored or has particles floating in it, do not use it
Beyond drugs, a growing number of companies are targeting the behavioral side of weight loss, combining these approaches with GLP-1 treatments to improve outcomes
Are there negative side effects of BPC-157
Study findings The study leveraged a total of 114 adult non-diabetic participants (randomized 1:1:1 to tirzepatide [n=37], liraglutide [n=38], or placebo [n=39])